Commentary: Polygenic risk for breast cancer: in search for potential clinical utility

Tingting Wang¹, Mika Ala-Korpela^{2

3

4}

Affiliations

¹ Baker Heart and Diabetes Institute, Melbourne, VIC, Australia.
² Computational Medicine, Faculty of Medicine, University of Oulu and Biocenter Oulu, Oulu, Finland.
³ Center for Life Course Health Research, University of Oulu, Oulu, Finland.
⁴ NMR Metabolomics Laboratory, School of Pharmacy, University of Eastern Finland, Kuopio, Finland.

Comment

Tingting Wang et al. Int J Epidemiol. 2022.

. 2022 Jan 6;50(6):1911-1913.

doi: 10.1093/ije/dyab230. Epub 2021 Oct 31.

Tingting Wang¹, Mika Ala-Korpela^{2

3

4}

¹ Baker Heart and Diabetes Institute, Melbourne, VIC, Australia.
² Computational Medicine, Faculty of Medicine, University of Oulu and Biocenter Oulu, Oulu, Finland.
³ Center for Life Course Health Research, University of Oulu, Oulu, Finland.
⁴ NMR Metabolomics Laboratory, School of Pharmacy, University of Eastern Finland, Kuopio, Finland.

No abstract available

Comment on

Prospective evaluation of a breast-cancer risk model integrating classical risk factors and polygenic risk in 15 cohorts from six countries.
Hurson AN, Pal Choudhury P, Gao C, Hüsing A, Eriksson M, Shi M, Jones ME, Evans DGR, Milne RL, Gaudet MM, Vachon CM, Chasman DI, Easton DF, Schmidt MK, Kraft P, Garcia-Closas M, Chatterjee N; B-CAST Risk Modelling Group. Hurson AN, et al. Int J Epidemiol. 2022 Jan 6;50(6):1897-1911. doi: 10.1093/ije/dyab036. Epub 2021 Mar 23. Int J Epidemiol. 2022. PMID: 34999890 Free PMC article.

1. Roberts MC. Implementation challenges for risk-stratified screening in the era of precision medicine. JAMA Oncol 2018;4:1484–85. - PubMed
1. Khan SS, Cooper R, Greenland P.. Do polygenic risk scores improve patient selection for prevention of coronary artery disease? JAMA 2020;323:614–15. - PubMed
1. Ala-Korpela M, Holmes MV.. Polygenic risk scores and the prediction of common diseases. Int J Epidemiol 2020;49:1–3. - PMC - PubMed
1. Lee A, Mavaddat N, Wilcox AN. et al. BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors. Genet Med 2019;21:1708–18. - PMC - PubMed
1. Mars N, Koskela JT, Ripatti P. et al. Polygenic and clinical risk scores and their impact on age at onset and prediction of cardiometabolic diseases and common cancers. Nat Med 2020;26:549–57. - PubMed